Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Tuberculosis | Research article

T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia

Authors: Tadelo Wondmagegn, Debasu Damtie, Meaza Genetu, Belete Biadgo, Mulualem Lemma, Markos Negash

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Tuberculosis continues to be a health problem of both developed and developing countries, and its incidence has currently increased due to HIV induced immune suppression. HIV-co-infection decreases the total number of CD4+ T cells since the virus preferentially replicates with in activated CD4+ T cells and macrophages, resulting in the disruption of granuloma to contain M. tuberculosis. In this study, we investigated the change in T lymphocyte subpopulations before and after anti-tubercular treatment and the effect of intestinal parasites on the cell populations of tuberculosis patients before the initiation of anti TB treatment.

Method

A prospective cohort study was conducted in the outpatient TB Clinic, University of Gondar hospital between January 2014 and August 2015. Blood samples were collected from 80 newly diagnosed TB patients with and without HIV co-infection. The mean CD4+ and CD8+ T lymphocyte counts of the patients were assessed before and after the course of anti-TB treatment. The mean values of T lymphocytes of TB, TB/HIV co-infected patients and of the control groups were compared. Data was analyzed by SPSS version 16 and the graph pad prism software.

Results

A total of 80 tuberculosis patients 40 of whom were co-infected with HIV participated in our study. The mean CD4 + T lymphocytes counts of the TB/HIV cohort were 354.45 ± 138cell/μl, and the mean CD8+ cell counts were 926.82 ± 384cell/μl. There were significant changes in the mean CD4+ and CD8+ T cell counts after the course of anti-TB treatment in both groups of patients(p < 0.05). However, no statistically significant differences were observed in the mean CD4 + and CD8+ T cell counts of helminthes infected and non-infected patients (P > 0.05).

Conclusion

We found significantly lower CD4+ T cell counts among TB infected HIV negative patients compared with controls who showed that TB was the cause of non–HIV-associated declination of circulating CD4 counts, and the reduction was reversible with anti-tubercular treatment in both HIV-negative and ART naïve TB-HIV co-infected patients.
Literature
1.
go back to reference Chadha VK. Progress towards millennium development goals for TB control in seven Asian countries. Indian J Tuberculosis. 2009;56:30–43. Chadha VK. Progress towards millennium development goals for TB control in seven Asian countries. Indian J Tuberculosis. 2009;56:30–43.
2.
go back to reference Loudon RG, Bumgarner LR, Lacy J, Coffman GK. Aerial transmission of mycobacteria. Am Rev Respir Dis. 1969;100:165–71.PubMed Loudon RG, Bumgarner LR, Lacy J, Coffman GK. Aerial transmission of mycobacteria. Am Rev Respir Dis. 1969;100:165–71.PubMed
3.
go back to reference Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011;24:351–76.CrossRef Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011;24:351–76.CrossRef
5.
go back to reference Maher D, Harries A, Getahun H. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Tropical Med Int Health. 2005 Aug;10(8):734–42.CrossRef Maher D, Harries A, Getahun H. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Tropical Med Int Health. 2005 Aug;10(8):734–42.CrossRef
6.
go back to reference UNAIDS ‘East and Southern Africa: Data 2016’ (Accessed 01 Nov 2018). UNAIDS ‘East and Southern Africa: Data 2016’ (Accessed 01 Nov 2018).
7.
go back to reference Harrington M. From HIV to tuberculosis and back again: a tale of activism in 2 pandemics. Clin Infect Dis. 2010;50:260–6.CrossRef Harrington M. From HIV to tuberculosis and back again: a tale of activism in 2 pandemics. Clin Infect Dis. 2010;50:260–6.CrossRef
9.
go back to reference Diedrich CR, Flynn JL. HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun. 2011;79(4):1407–17.CrossRef Diedrich CR, Flynn JL. HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun. 2011;79(4):1407–17.CrossRef
10.
go back to reference Lawn SD, Butera ST, Shinnick TM. Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to mycobacterium tuberculosis. Microbes Infect. 2002;4(6):635–46.CrossRef Lawn SD, Butera ST, Shinnick TM. Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to mycobacterium tuberculosis. Microbes Infect. 2002;4(6):635–46.CrossRef
11.
go back to reference Al-Aska A, Al-Anazi A, Al-Subaei S, Al-Hedaithy M, Barry M, Somily A, et al. CD4+ T-lymphopenia in HIV negative tuberculous patients at King Khalid University Hospital in Riyadh, Saudi Arabia. Eur J Med Res. 2011;16(6):285.CrossRef Al-Aska A, Al-Anazi A, Al-Subaei S, Al-Hedaithy M, Barry M, Somily A, et al. CD4+ T-lymphopenia in HIV negative tuberculous patients at King Khalid University Hospital in Riyadh, Saudi Arabia. Eur J Med Res. 2011;16(6):285.CrossRef
12.
go back to reference Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today. 1995;16(4):187–91.CrossRef Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today. 1995;16(4):187–91.CrossRef
13.
go back to reference Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, et al. Purified protein derivative of mycobacterium tuberculosis and excretory-secretory antigen (s) of Toxocaracanis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest. 1991;88(1):346–50.CrossRef Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, et al. Purified protein derivative of mycobacterium tuberculosis and excretory-secretory antigen (s) of Toxocaracanis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest. 1991;88(1):346–50.CrossRef
16.
go back to reference Uppal S, Tewari S, Verma S, Dhot P. Comparison of CD4 and CD8 lymphocyte counts in HIV-negative pulmonary TB patients with those in normal blood donors and the effect of antitubercular treatment: hospital-based flow cytometric study. Cytometry B Clin Cytom. 2004;61(1):20–6.CrossRef Uppal S, Tewari S, Verma S, Dhot P. Comparison of CD4 and CD8 lymphocyte counts in HIV-negative pulmonary TB patients with those in normal blood donors and the effect of antitubercular treatment: hospital-based flow cytometric study. Cytometry B Clin Cytom. 2004;61(1):20–6.CrossRef
17.
go back to reference Swaminathan S, Sangeetha M, Arunkumar N, Menon P, Thomas B, Shibi K, et al. Pulmonary tuberculosis in HIV individuals: preliminary report on clinical features and response to treatment. Indian J Tuberc. 2002;49(4):189–93. Swaminathan S, Sangeetha M, Arunkumar N, Menon P, Thomas B, Shibi K, et al. Pulmonary tuberculosis in HIV individuals: preliminary report on clinical features and response to treatment. Indian J Tuberc. 2002;49(4):189–93.
18.
go back to reference Vashishtha R, Mohan K, Singh B, Devarapu SK, Sreenivas V, Ranjan S, et al. Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study. BMC Infect Dis. 2013;13(1):468.CrossRef Vashishtha R, Mohan K, Singh B, Devarapu SK, Sreenivas V, Ranjan S, et al. Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study. BMC Infect Dis. 2013;13(1):468.CrossRef
19.
go back to reference Jones BE, Oo MM, Taikwel EK, Qian D, Kumar A, Maslow ER, et al. CD4 cell counts in human immunodeficiency virus—negative patients with tuberculosis. Clin Infect Dis. 1997;24(5):988–91.CrossRef Jones BE, Oo MM, Taikwel EK, Qian D, Kumar A, Maslow ER, et al. CD4 cell counts in human immunodeficiency virus—negative patients with tuberculosis. Clin Infect Dis. 1997;24(5):988–91.CrossRef
20.
go back to reference Kavya S, Anuradha K, Venkatesha D. CD4 count evaluation in HIV-TB co infection before and after anti-tubercular treatment. Int J Res Med Sci. 2017;2(3):1031–4. Kavya S, Anuradha K, Venkatesha D. CD4 count evaluation in HIV-TB co infection before and after anti-tubercular treatment. Int J Res Med Sci. 2017;2(3):1031–4.
21.
go back to reference Hanna L, Nayak K, Subramanyam S, Venkatesan P, Narayanan P, Swaminathan S. Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis. Indian J Med Res. 2009;129(5):548.PubMed Hanna L, Nayak K, Subramanyam S, Venkatesan P, Narayanan P, Swaminathan S. Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis. Indian J Med Res. 2009;129(5):548.PubMed
22.
go back to reference Mahan CS, Walusimbi M, Johnson DF, Lancioni C, Charlebois E, Baseke J, et al. Tuberculosis treatment in HIV infected Ugandans with CD4 counts> 350 cells/mm3 reduces immune activation with no effect on HIV load or CD4 count. PLoS One. 2010;5(2):e9138.CrossRef Mahan CS, Walusimbi M, Johnson DF, Lancioni C, Charlebois E, Baseke J, et al. Tuberculosis treatment in HIV infected Ugandans with CD4 counts> 350 cells/mm3 reduces immune activation with no effect on HIV load or CD4 count. PLoS One. 2010;5(2):e9138.CrossRef
23.
go back to reference McSorley HJ, Maizels RM. Helminth infections and host immune regulation. Clin Microbiol Rev. 2012;25(4):585–608.CrossRef McSorley HJ, Maizels RM. Helminth infections and host immune regulation. Clin Microbiol Rev. 2012;25(4):585–608.CrossRef
24.
go back to reference Kassu A, Tsegaye A, Wolday D, Petros B, Aklilu M, Sanders E, et al. Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clin Exp Immunol. 2003;132(1):113–9.CrossRef Kassu A, Tsegaye A, Wolday D, Petros B, Aklilu M, Sanders E, et al. Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clin Exp Immunol. 2003;132(1):113–9.CrossRef
Metadata
Title
T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia
Authors
Tadelo Wondmagegn
Debasu Damtie
Meaza Genetu
Belete Biadgo
Mulualem Lemma
Markos Negash
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-4845-y

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue